T1	Participants 40 54	heroin addicts
T2	Participants 101 136	a group of long-term heroin addicts
T3	Participants 317 406	patients manifested some subjective symptoms but few objective signs of opioid withdrawal
T4	Participants 408 446	Patients who received placebo (n = 18)
T5	Participants 559 598	Patients who received naloxone (n = 58)
T6	Participants 747 920	Sixty-one percent of patients failed to manifest clinically significant changes in subjective symptoms, and 74% of patients failed to manifest clinically significant changes
T7	Participants 1008 1095	suggest that a substantial subgroup of heroin addicts are able to use opioids regularly
